Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-030300

EVP, Head of R&D sold 4,124 shares at $5.03 ($20,760)

From the SEC's structured data for this filing

Trades in this filing

Dupont Jakob · EVP, Head of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-16 Sale : show line 1 in the form −4,124 $5.03 $20,760 158,882 D
Open-market sales · 4,124 sh · avg $5.03 · $20,760
Loading xslF345X03/form4.xml…